{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-024273","form_type":"8-K","ticker":"INFU","cik":"0001337013","company_name":"InfuSystem Holdings, Inc","filed_at":"2025-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.014219+00:00","generated_at":"2026-05-22T01:27:59.413146+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"InfuSystem provides FY2025 outlook: 8-10% revenue growth, high-teens AEBITDA margin","bullets":["TTM revenue to March 31, 2025: $137.6M; TTM adj. EBITDA $27.8M (leverage 0.98x).","Q1 2025 adj. EBITDA $6.3M (incl. $1.0M CEO severance) vs. $3.9M in Q1 2024.","FY2025 guidance: revenue growth 8-10% and adj. EBITDA margin in high teens % of revenue.","ERP upgrade: $0.7M spent in 2024, est. $2.5M in 2025; completion expected Q1 2026.","Share repurchases: $4.1M bought YTD under renewed $20M program (expires June 2026)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-024273","json":"https://secwatch.observer/filing/0001628280-25-024273.json","markdown":"https://secwatch.observer/filing/0001628280-25-024273.md","text":"https://secwatch.observer/filing/0001628280-25-024273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025024273/0001628280-25-024273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025024273/infu-20250509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T01:27:59.413146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}